Phase 1, QT/QTC Interval Study in Healthy Subjects

NCT01910415 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Lumacaftor
DRUG: Lumacaftor Placebo
DRUG: Ivacaftor
DRUG: Ivacaftor Placebo
DRUG: moxifloxacin hydrochloride

Sponsor

Vertex Pharmaceuticals Incorporated